LABT
Lakewood-Amedex Biotherapeutics Inc.
Going-concern doubt
— flagged May 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”View the 10-Q filed May 22, 2026
Company with tickers: LABT
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.